Dejerine-Sottas disease with a novel de novo dominant mutation, Ser 149 Arg, of the peripheral myelin protein 22

Springer Science and Business Media LLC - Tập 99 - Trang 327-330 - 2000
A. Ohnishi1, T. Yamamoto1, K. Izawa2, S. Yamamori2, K. Takahashi3, H. Mega3, K. Jinnai3
1Department of Neurology, School of Medicine, University of Occupational and Environmental Health, 1-1, Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan e-mail: [email protected], Tel.: +81-93-691-7438, Fax: +81-93-693-9842, , JP
2Department of Gene Analysis, Mitsubishi-Kagaku, Bio-Clinical Laboratories Inc., Tokyo, Japan, , JP
3Department of Neurology, National Sanatorium Hyogo Chuo Hospital, Sanda, Hyogo, Japan, , JP

Tóm tắt

The Ser149Arg mutation of peripheral myelin protein 22 (PMP22) was found in a 19-year-old woman with a sporadic case of Dejerine-Sottas disease. The patient showed delayed motor development. She walked for the first time with support at the age of 2 years. Scoliosis developed at age 4 years. Her walking ability was best at age 11. Thereafter, she showed progressive muscle weakness and sensory disturbances in the distal extremities. At the age of 18 years, the use of a wheelchair became necessary. Motor and sensory nerve conduction studies showed absent motor and sensory responses on electrical stimulation of the limb nerves. A sural nerve biopsy specimen showed marked decreases in the numbers of both large and small myelinated fibers, abundant onion-bulb formation, and hypomyelination. Electron microscopic observation revealed the presence of demyelinated axons and myelin sheaths disproportionately thin relative to axon diameter. That this was a de novo mutation was established by parentage testing and PMP22 gene analysis of the parents. The mutation seems to be novel and dominant.